To the Editor We read with great interest the article by Wang et al, wherein they reviewed 57 articles pertaining to the 4 low-value breast cancer (BC) operations defined by the Choosing Wisely campaign.1 We commend the authors for presenting opportunities for deimplementation of low-value procedures to reduce health care waste. However, with regards to omission of sentinel lymph node biopsy (SLNB) in elderly patients with stage I, estrogen-receptor positive BC (ER+BC), there are important caveats to consider.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Park KU, Bazan JG. Implications of Omitting Sentinel Lymph Node Biopsy in Patients Older Than 70 Years. JAMA Surg. 2021;156(2):199–200. doi:10.1001/jamasurg.2020.5008
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.